| Primary |
| Parkinson's Disease |
42.9% |
| Hyperlipidaemia |
28.6% |
| Sleep Apnoea Syndrome |
28.6% |
|
| Cerebrovascular Accident |
50.0% |
| Rhabdomyolysis |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
40.0% |
| Hypertension |
13.3% |
| Type 2 Diabetes Mellitus |
13.3% |
| Blood Cholesterol Increased |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Rheumatoid Arthritis |
4.4% |
| Arterial Occlusive Disease |
2.2% |
| Coronary Artery Disease |
2.2% |
| Fluid Retention |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Hyperparathyroidism |
2.2% |
| Lipid Metabolism Disorder |
2.2% |
| Prophylaxis |
2.2% |
| Q Fever |
2.2% |
| Renal Failure |
2.2% |
|
| Musculoskeletal Pain |
16.7% |
| Pain In Extremity |
16.7% |
| Rash Pruritic |
16.7% |
| Rhabdomyolysis |
16.7% |
| Synovitis |
16.7% |
| Tendonitis |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Hypertension |
17.1% |
| Drug Use For Unknown Indication |
12.6% |
| Non-small Cell Lung Cancer |
5.1% |
| Type 2 Diabetes Mellitus |
5.1% |
| Blood Cholesterol Increased |
4.4% |
| Gastric Cancer |
3.8% |
| Rheumatoid Arthritis |
3.5% |
| Diabetes Mellitus |
3.2% |
| Atrial Fibrillation |
3.1% |
| Dyspepsia |
2.4% |
| Pain |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Depression |
2.3% |
| Osteoporosis |
2.3% |
| Prophylaxis |
2.1% |
| Ischaemic Heart Disease Prophylaxis |
2.0% |
| Metastatic Gastric Cancer |
2.0% |
| Multiple Myeloma |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
|
| Vomiting |
10.1% |
| Septic Shock |
9.1% |
| Weight Decreased |
8.1% |
| Renal Failure Acute |
7.1% |
| Vision Blurred |
7.1% |
| Myocardial Infarction |
6.1% |
| Thrombocytopenia |
6.1% |
| Pneumonia |
5.1% |
| Febrile Neutropenia |
4.0% |
| Hypokalaemia |
4.0% |
| Renal Failure Chronic |
4.0% |
| Sepsis |
4.0% |
| Urinary Tract Infection |
4.0% |
| Blood Creatinine Increased |
3.0% |
| Cholelithiasis |
3.0% |
| Infection |
3.0% |
| Nausea |
3.0% |
| Pain |
3.0% |
| Pulmonary Embolism |
3.0% |
| Tumour Haemorrhage |
3.0% |
|
| Interacting |
| Acute Myocardial Infarction |
13.6% |
| Drug Use For Unknown Indication |
9.1% |
| Essential Hypertension |
9.1% |
| Arthralgia |
4.5% |
| Atrial Fibrillation |
4.5% |
| Atrial Flutter |
4.5% |
| Blood Cholesterol Increased |
4.5% |
| Constipation |
4.5% |
| Eczema |
4.5% |
| Gastric Ulcer |
4.5% |
| Hypercholesterolaemia |
4.5% |
| Hypothyroidism |
4.5% |
| Insomnia |
4.5% |
| Lower Respiratory Tract Infection |
4.5% |
| Peptic Ulcer |
4.5% |
| Pharyngitis |
4.5% |
| Polyarthritis |
4.5% |
| Prophylaxis |
4.5% |
|
| Haemoptysis |
25.0% |
| Myalgia |
25.0% |
| Shock Haemorrhagic |
25.0% |
| Tendon Rupture |
25.0% |
|
